Fernández-del Castillo C, Schmidt J, Rattner D W, Lewandrowski K, Compton C C, Jehanli A, Patel G, Hermon-Taylor J, Warshaw A L
Department of Surgery, Masschusetts General Hospital, Boston 02114.
Pancreas. 1992;7(3):263-70. doi: 10.1097/00006676-199205000-00001.
Trypsinogen activation peptides (TAP) were quantified by radioimmunoassay in blood, urine, and peritoneal exudate of rats with experimental pancreatitis. Forty-four animals were studied, comprising a control group and four different induction techniques (cerulein, cerulein plus either 2- or 10-min intraductal glycodeoxycholic acid [GDOC] infusion, and cerulein plus intraductal GDOC with enterokinase [EK]). Significantly higher TAP concentrations were found at 6 h (or at death) in plasma and ascites of all pancreatitis groups compared with controls. TAP quantitation in hourly urine samples demonstrated significantly higher concentrations from the third hour onward in the most severe groups and from the fourth hour onward in the cerulein-treated rats. All nonsurviving rats had a plasma TAP of greater than 2.5 nM/L, whereas only 1 of 34 surviving animals had such a concentration (p less than 0.001). A significant stepwise increase in total TAP in ascites was found when comparing the cerulein group, the two GDOC groups, and the EK group (p less than 0.001). Chromatography of samples with a high TAP content demonstrated comigration with synthetic TAP. We conclude that free TAP are present in blood, urine, and peritoneal exudate of rats with experimental pancreatitis of different pathogenesis and that the amount of TAP may be indicative of the severity of the disease process.
采用放射免疫分析法对实验性胰腺炎大鼠的血液、尿液及腹腔渗出液中的胰蛋白酶原激活肽(TAP)进行定量分析。共研究了44只动物,包括一个对照组以及四种不同的诱导技术组(蛙皮素组、蛙皮素加2分钟或10分钟胆管内注入甘氨脱氧胆酸[GDOC]组、蛙皮素加胆管内注入GDOC及肠激酶[EK]组)。与对照组相比,所有胰腺炎组在6小时(或死亡时)血浆和腹水中的TAP浓度显著更高。每小时尿液样本中的TAP定量显示,在最严重的组中从第3小时起、在蛙皮素处理的大鼠中从第4小时起浓度显著更高。所有未存活的大鼠血浆TAP均大于2.5 nM/L,而34只存活动物中只有1只达到此浓度(p<0.001)。比较蛙皮素组、两个GDOC组和EK组时,腹水中总TAP呈显著逐步增加(p<0.001)。对TAP含量高的样本进行色谱分析显示与合成TAP共迁移。我们得出结论,在不同发病机制的实验性胰腺炎大鼠的血液、尿液和腹腔渗出液中存在游离TAP,且TAP的量可能表明疾病进程的严重程度。